Drugs / GVAX lung cancer vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00074295 | Mar 2004 → Aug 2007 | lung cancer | SWOG Cancer Research Network | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GVAX lung cancer vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00074295 ↗ |
| Modality | Vaccine | “GVAX lung cancer vaccine” NCT00074295 ↗ |
| Route | Other | “patients receive GVAX lung cancer vaccine intradermally (ID)” NCT00074295 ↗ |